1 completed, 1 unknown. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Schedule Change: new trials by email Literature Review of Schedule Change trials Research Report on Schedule Change
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Work Time Schedule Changes for Nurse Managers Schedule Change, No Schedule Change - Work-Related Condition | Not applicable | Unknown | University of California, Los Angeles | 50 | 2025-01-01 | 2024-11-14 |
| Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily Roflumilast alternated days, Roflumilast 500 mcg per day - Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | Fundación Pública Andaluza Progreso y Salud | 105 | 2012-07-01 | 2015-07-08 |
Pulmonary Disease, Chronic Obstructive (1)
Fundación Pública Andaluza Progreso y Salud (1) · University of California, Los Angeles (1)
Spain (1) · United States (1)
Gregorio Soto, M.D. (1) · Jian Li, MD, PhD (1) · Rosa Vazquez, M.D. (1) · Ruth Ayerbe, M.D (1) · Teodoro Montemayor Rubio, M.D. Ph D (1)